跳至主要内容
临床试验/NCT01627145
NCT01627145Unknown不适用

Post-treatment Normallized Urodynamic Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug and Its Correlations With Voiding Diary, King's Health Questionnaire, and Overactive Bladder Sympto

National Taiwan University Hospital1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2012年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
300
试验地点
1
主要终点
The percentage of normalized urodynamic pattern after treatment

研究概览

简要总结

Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug and Its Conelations With Voiding Diary, King's Health Quentionaire, Overactive Bladder Sympton Scores and Patient Perception of Bladder Condition.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • female patients within 18 years old to 99 years old with overactive bladder syndrome

排除标准

  • unwilling or unable to perform testing procedure

研究组 & 干预措施

antimuscariniz drug

Experimental

干预措施: Solifenacin (Drug)

结局指标

主要结局

The percentage of normalized urodynamic pattern after treatment

时间窗: 12 weeks

次要结局

  • The percentage of recurrence rates after treatment during follow-up and further to analyze the risk factors of recurrence(48 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

National Taiwan University Hospital

Professor, Department of Obstetrics & Gynecology

National Taiwan University Hospital

研究点 (1)

Loading locations...

相似试验

Post-treatment Novmalized Urodynamiz Findings as the... | 临床试验